Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis

被引:0
|
作者
Liu, Zhiyao [1 ]
Huang, Hailiang [1 ]
Yu, Ying [2 ]
Jia, Yuqi [1 ]
Li, Lingling [1 ]
Shi, Xin [1 ]
Wang, Fangqi [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Dept Rehabil Med, Jinan 250355, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Jinan 250355, Shandong, Peoples R China
关键词
Colchicine; coronavirus disease-19; non-small cell lung cancer; network pharmacology; bioinformatics analysis; molecular docking; molecular dynamics simulation; INTERLEUKIN-17; DISEASE; LESIONS; GENES; IL-17; DRUG;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colchicine is an alkaloid with antitumor effect isolated from Colchicum autumnale plants, it has been reported in multiple studies as a potential treatment for coronavirus disease-19 and this study applied network pharmacology and bioinformatics analysis to explore the potential mechanism of colchicine against non-small cell lung cancer and coronavirus disease-19. The R software was used to determine the differentially expressed genes of non-small cell lung cancer/coronavirus disease-19, and carry out prognostic analysis and clinical analysis of the differentially expressed genes, the targets of colchicine were obtained from various databases, the protein-protein interaction network of intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 was constructed, enrichment analysis of gene ontology and kyoto encyclopedia of genes and genomes pathways was performed by Metascape database and the molecular docking and molecular dynamics simulation were completed. We obtained a total of 716 differentially expressed genes and identified 13 potential prognostic genes associated with the clinical characterization of non-small cell lung cancer/coronavirus disease-19 patients. C-C motif chemokine ligand 2, toll like receptor 4, intercellular adhesion molecule 1, peroxisome proliferator activated receptor gamma, interleukin 17A, interferon gamma, angiotensin I converting enzyme, fos proto-oncogene, nuclear factor kappa B inhibitor alpha, TIMP metallopeptidase inhibitor 1 and secreted phosphoprotein 1 were core targets. The intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 were mainly enriched in biological processes such as inflammatory response, response to cytokine and response to lipopolysaccharide, as well as signal pathways such as interleukin 17 signaling pathway, hypoxia inducible factor 1 signaling pathway and nucleotide binding oligomerization domain-like receptor signaling pathway. The results of molecular docking showed that the colchicine is better combined with the core targets. Analysis of molecular dynamics simulation showed that the protein and ligand form a stabilizing effect. Based on bioinformatics analysis and network pharmacology, we obtained biomarkers that may be used for the prognosis of non-small cell lung cancer/coronavirus disease-19 patients and revealed that colchicine may play a potential role in the treatment of non-small cell lung cancer/coronavirus disease-19 by regulating multiple targets and multiple signaling pathways and participating in multiple biological processes.
引用
收藏
页码:199 / 216
页数:18
相关论文
共 50 条
  • [31] Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer
    Yu, Hui
    Pang, Zhonghao
    Li, Gang
    Gu, Tianyi
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (02)
  • [32] Analysis of signaling network in non-small cell lung cancer
    Liu Wei
    Ye Fei
    Li Guanghu
    Wu Yong
    Wang Libo
    Glaser, Laurel
    Yin Guanghao
    Xue Menghua
    Zhu Dongshan
    Zhang, David Y.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S628 - S628
  • [33] Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer
    Xiao, Wenke
    Xu, Yaxin
    Baak, Jan P.
    Dai, Jinrong
    Jing, Lijia
    Zhu, Hongxia
    Gan, Yanxiong
    Zheng, Shichao
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [34] Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer
    Wenke Xiao
    Yaxin Xu
    Jan P. Baak
    Jinrong Dai
    Lijia Jing
    Hongxia Zhu
    Yanxiong Gan
    Shichao Zheng
    BMC Complementary Medicine and Therapies, 23
  • [35] Modeling the Impact of Delaying the Diagnosis of Non-Small Cell Lung Cancer During COVID-19
    Shipe, Maren E.
    Haddad, Diane N.
    Deppen, Stephen A.
    Kozower, Benjamin D.
    Grogan, Eric L.
    ANNALS OF THORACIC SURGERY, 2021, 112 (01): : 248 - 254
  • [36] Perspective: Did Covid-19 Change Non-small Cell Lung Cancer Surgery Approach?
    Ciriaco, Paola
    Carretta, Angelo
    Bandiera, Alessandro
    Muriana, Piergiorgio
    Negri, Giampiero
    FRONTIERS IN SURGERY, 2021, 8
  • [37] To explore the effect of kaempferol on non-small cell lung cancer based on network pharmacology and molecular docking
    Zhang, Junli
    Liu, Xiangqi
    Zhang, Guoying
    Wu, Junling
    Liu, Zhongfang
    Liu, Chuanguo
    Wang, Hui
    Miao, Shuxin
    Deng, Lei
    Cao, Kuan
    Shang, Miwei
    Zhu, Qingjun
    Sun, Peng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [38] Exploration of kiwi root on non-small cell lung cancer based on network pharmacology and molecular docking
    Li, Ruochen
    Wang, Mingxiao
    Tian, Jin
    Liu, Minghui
    Li, Gaigai
    Zhou, Xun
    MEDICINE, 2024, 103 (01) : E36852
  • [39] Identification of potential hub genes and biological mechanism in rheumatoid arthritis and non-small cell lung cancer via integrated bioinformatics analysis
    An, Junsha
    Chen, Pingting
    Li, Xin
    Li, Xiuchuan
    Peng, Fu
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [40] Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (Cremastra appendiculata) Against Non-Small Cell Lung Cancer
    Wang, Yan
    Zhang, Yunwu
    Wang, Yujia
    Shu, Xinyao
    Lu, Chaorui
    Shao, Shiliang
    Liu, Xingting
    Yang, Cheng
    Luo, Jingsong
    Du, Quanyu
    FRONTIERS IN CHEMISTRY, 2021, 9